Unlike traditional pharmaceuticals, cell and gene therapies demand highly controlled, flexible, and contamination-free environments. Each therapy may require customized production processes, which makes facility adaptability and scalable infrastructure critical. A turnkey solution ensures that organizations can move from concept to commercial supply efficiently, while meeting strict global regulatory expectations (FDA, EMA, MHRA, PMDA, WHO).